These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 422703)

  • 1. Effect of metoclopramide, a dopaminergic inhibitor, on renin and aldosterone in idiopathic edema: possible therapeutic approach with levodopa and carbidopa.
    Norbiato G; Bevilacqua M; Raggi U; Micossi P; Nitti F; Lanfredini M; Barbieri S
    J Clin Endocrinol Metab; 1979 Jan; 48(1):37-42. PubMed ID: 422703
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of bromocriptine on renin, aldosterone, and prolactin responses to posture and metoclopramide in idiopathic edema: possible therapeutic approach.
    Sowers J; Catania R; Paris J; Tuck M
    J Clin Endocrinol Metab; 1982 Mar; 54(3):510-6. PubMed ID: 7035482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of sodium homeostasis on dopaminergic modulation of aldosterone, renin, and prolactin secretion in man.
    Sowers JR; Glub MS; Eggena PH; Catania RA
    J Clin Endocrinol Metab; 1982 Jan; 54(1):121-6. PubMed ID: 7033264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered dopaminergic modulation of 18-hydroxycorticosterone secretion in idiopathic edema: therapeutic effects of bromocriptine.
    Sowers JR; Beck FW; Berg G
    J Clin Endocrinol Metab; 1982 Oct; 55(4):749-59. PubMed ID: 7050141
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapy of Parkinsonism dopaminergic drugs.
    Bianchine JR
    Ohio State Med J; 1977 Feb; 73(2):84-5. PubMed ID: 834419
    [No Abstract]   [Full Text] [Related]  

  • 7. The long-term effects of combining carbidopa with levodopa for Parkinson's disease.
    Lee MC; Lippert DM; Loewenson RB; Tolosa ES; Resch JA; Martin WE
    Trans Am Neurol Assoc; 1976; 101():262-4. PubMed ID: 829295
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor].
    Londoõ R
    Neurol Neurocir Psiquiatr; 1976; 17(4):293-300. PubMed ID: 1018729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report.
    Savery F
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):337-8. PubMed ID: 817863
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa].
    Lombardo L; De la Garza R
    Arch Invest Med (Mex); 1977; 8(2):123-8. PubMed ID: 907417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of Parkinson's syndromes by a combination of levodopa with decarboxylase inhibitors].
    Hanzal F
    Cesk Neurol Neurochir; 1975 Dec; 38(6):327-32. PubMed ID: 1192544
    [No Abstract]   [Full Text] [Related]  

  • 12. Diurnal variation of plasma renin activity, aldosterone and cortisol in idiopathic edema.
    Katz FH
    J Clin Endocrinol Metab; 1977 Sep; 45(3):419-24. PubMed ID: 561805
    [No Abstract]   [Full Text] [Related]  

  • 13. [The clinical experience with the decarboxylase-blocked levodopa (Nacom) in the Parkinsonism patients].
    Völler GW; Deze J
    ZFA (Stuttgart); 1976 Mar; 52(7):380-8. PubMed ID: 773025
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the responses of plasma renin activity and aldosterone and cortisol levels to dopaminergic and opiate stimuli in man.
    Lightman SL
    Clin Endocrinol (Oxf); 1981 Jul; 15(1):45-52. PubMed ID: 7030527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of studies on the treatment of parkinsonian syndromes with levodopa. II. Long-term effects of L-DOPA alone or in combination with a decarboxylase inhibitor].
    Rabadeau Dumas JL; Rondot P; Cardon P
    Therapie; 1977; 32(2):161-72. PubMed ID: 898124
    [No Abstract]   [Full Text] [Related]  

  • 16. [Carbiodopa-levodopa therapy (Sinemet) in the treatment of parkinsonian patients. Results of 4 years of treatment].
    Martínez-Lage JM; Burguera JA; Deldago G; Zubieta JL
    Arch Neurobiol (Madr); 1978; 41(1):3-18. PubMed ID: 697513
    [No Abstract]   [Full Text] [Related]  

  • 17. [Proceedings: Detection of renin-angiotensin-aldosterone system in idiopathic edema].
    Yamamoto T; Doi H; Omori K; Ogihara T; Kumahara Y
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):440. PubMed ID: 4375588
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug therapy for Parkinsonism.
    Walker E
    Mod Healthc (Short Term Care); 1976 Jan; 5(1):62. PubMed ID: 1652
    [No Abstract]   [Full Text] [Related]  

  • 19. Sinemet.
    Drug Ther Bull; 1974 Oct; 12(21):83-4. PubMed ID: 4617660
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: Alternatives to levodopa.
    Hildick-Smith M
    Br Med J; 1976 Jun; 1(6022):1406. PubMed ID: 1276722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.